AR070617A1 - Formulacion farmaceutica que comprende oxabispidinas/236 - Google Patents
Formulacion farmaceutica que comprende oxabispidinas/236Info
- Publication number
- AR070617A1 AR070617A1 ARP090100600A ARP090100600A AR070617A1 AR 070617 A1 AR070617 A1 AR 070617A1 AR P090100600 A ARP090100600 A AR P090100600A AR P090100600 A ARP090100600 A AR P090100600A AR 070617 A1 AR070617 A1 AR 070617A1
- Authority
- AR
- Argentina
- Prior art keywords
- modified release
- oxabispidins
- pharmaceutical
- pharmaceutical formulation
- pharmaceutical use
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Una formulacion de liberacion modificada que comprende oxabispidinas, como ingrediente activo, o una de sus sales aceptables para uso farmacéutico; y un portador o diluyente farmacéuticamente aceptable; para el uso en el tratamiento o la prevencion de arritmias cardiacas. Reivindicacion 1: Una formulacion farmacéutica de liberacion modificada en forma de un sistema unitario multiple, que comprende: I) miniesferas de liberacion inmediata que comprenden Compuesto A, o una de sus sales aceptables para uso farmacéutico; II miniesferas de liberacion modificada que comprenden compuesto A o una de sus sales aceptables para uso farmacéutico, revestidas con una membrana de difusion formada por material polimérico formador de película; en una relacion de las miniesferas de acuerdo con I) y II) de entre 10:90 y 90:10.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3064308P | 2008-02-22 | 2008-02-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR070617A1 true AR070617A1 (es) | 2010-04-21 |
Family
ID=40985767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090100600A AR070617A1 (es) | 2008-02-22 | 2009-02-20 | Formulacion farmaceutica que comprende oxabispidinas/236 |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR070617A1 (es) |
| PE (1) | PE20091464A1 (es) |
| TW (1) | TW200940110A (es) |
| UY (1) | UY31669A1 (es) |
| WO (1) | WO2009105023A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104586809A (zh) * | 2015-01-08 | 2015-05-06 | 浙江亚太药业股份有限公司 | 一种埃索美拉唑镁微丸肠溶片及制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6500457B1 (en) * | 2000-08-14 | 2002-12-31 | Peirce Management, Llc | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
| US6344215B1 (en) * | 2000-10-27 | 2002-02-05 | Eurand America, Inc. | Methylphenidate modified release formulations |
| TWI259836B (en) * | 2001-04-12 | 2006-08-11 | Astrazeneca Ab | Modified release formulation suitable for antiarrhythmic compounds |
| US8367111B2 (en) * | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| CN101243093A (zh) * | 2005-06-13 | 2008-08-13 | 阿斯利康(瑞典)有限公司 | 用于治疗心律不齐的新型氧杂双哌啶化合物 |
| WO2007083323A2 (en) * | 2006-01-23 | 2007-07-26 | Panacea Biotec Limited. | Modified release oral dosage form comprising desmopressin |
| US20090196923A1 (en) * | 2006-04-26 | 2009-08-06 | Jayanta Kumar Mandal | Controlled release formulation comprising anti-epileptic drugs |
-
2009
- 2009-02-18 TW TW098105133A patent/TW200940110A/zh unknown
- 2009-02-19 WO PCT/SE2009/050184 patent/WO2009105023A1/en active Application Filing
- 2009-02-20 AR ARP090100600A patent/AR070617A1/es unknown
- 2009-02-20 UY UY031669A patent/UY31669A1/es unknown
- 2009-02-20 PE PE2009000255A patent/PE20091464A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20091464A1 (es) | 2009-10-24 |
| UY31669A1 (es) | 2009-09-30 |
| WO2009105023A1 (en) | 2009-08-27 |
| TW200940110A (en) | 2009-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122575T1 (el) | Φαρμακοτεχνικες μορφες διστρωματικου δισκιου | |
| UY30759A1 (es) | Compuestos quimicos | |
| CR11641A (es) | Derivados heterociclicos de urea y metodos de uso de los mismos-211 | |
| UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
| UY32315A (es) | Compuestos de piperidina y usos de los mismo-596 | |
| CL2011003266A1 (es) | Compuestos derivados de imidazolidin-2-ona, con actividad inhibidora de 17alfa-hidroxilasa/liasa-c17,20; composicion farmaceutica que los comprende; y uso en el tratamiento de inflamacion o cancer, entre otras. | |
| UY31141A1 (es) | Compuestos de piperidina y sus usos | |
| BR112012008317A2 (pt) | produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal | |
| CR20120104A (es) | Compuestos quimicos | |
| UY32816A (es) | Formulación farmacéutica a base de 1-[2-(2,1,3-benzotiadiazol-5-ilamino)-6(2,6-diclorofenil)-pirido[2,3-d] pirimidin-7-il]-3-tert-butil-uréa | |
| SV2010003451A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas | |
| ECSP10010598A (es) | Metodos y composiciones líquidas de limpieza | |
| CL2011000170A1 (es) | Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa. | |
| DOP2010000374A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
| CO6491060A2 (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
| AR072685A1 (es) | Composicion topica para el tratamiento de queratosis actinica | |
| UY31860A (es) | Piridinas de tiazolo como inhibidoras de la adn girasa | |
| UY32674A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
| CR11825A (es) | Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas | |
| UY32856A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos | |
| UY32316A (es) | Derivados de piperidina utiles en el tratamiento de infecciones bacterianas | |
| CL2011001829A1 (es) | 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo. | |
| CO6382113A2 (es) | Compuestos quimicos | |
| CL2011000292A1 (es) | Compuestos derivados de enfumafungina y sus sales farmaceuticamente aceptables, como inhibidores de (1,3)-beta-d-glucano sintasa; composicion farmaceutica; y uso para tratar una infeccion fungica. | |
| CR9839A (es) | Composicion farmaceutica fotoestable que contiene brivudina para el tratamiento de la queratitis herpetica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |